Aug 2026
Tumor subtype-specific transcriptional signatures predict recurrence risk in hepatocellular carcinoma.
Hyeran Shim, Hoang Bao Khanh Chu, Jiun Kim et al.
· BMB Reports · 0 citations
2 papers indexed here
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
It is found that KRAS mutations remodel the N6-methyladenosine (m6A) epitranscriptome to promote immune evasion and highlight METTL3 as a promising therapeutic target.